During the past decade, Dermatologikum Hamburg conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Dermatologikum Hamburg" #1 sponsor was "Eli Lilly and Company" with 2 trials, followed by "Incyte Corporation" with 2 trials sponsored, "Coherus Biosciences, Inc." with 1 trials sponsored, "HAL Allergy" with 1 trials sponsored and "Pierre Fabre Medicament" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dermatologikum Hamburg" #1 collaborator was "Clinact" with 1 trials as a collaborator, "Dermira, Inc." with 1 trials as a collaborator and "Shire" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Dermatologikum Hamburg" are "Atopic Dermatitis" (2 trials), "Actinic Keratoses" (1 trials), "Birch Pollen Induced Rhinitis/Rhinoconjunctivitis" (1 trials), "Chronic Hand Eczema (CHE)" (1 trials) and "Hand Eczema" (1 trials). Many other conditions were trialed in "Dermatologikum Hamburg" in a lesser frequency.

Most popular intervention types in "Dermatologikum Hamburg" are "Drug" (6 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ruxolitinib cream" (2 trials), "Vehicle" (2 trials), "5-fluorouracil 4% (Tolak)" (1 trials), "CHS-0214" (1 trials) and "Dexeryl" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dermatologikum Hamburg" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Dermatologikum Hamburg". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Dermatologikum Hamburg, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Dermatologikum Hamburg, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".